Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions

被引:4
|
作者
Bulkhi, Adeeb [1 ,2 ]
Tabatabaian, Farnaz [1 ]
Casale, Thomas B. [1 ]
机构
[1] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA
[2] Umm Al Qura Univ, Coll Med, Dept Internal Med, Mecca, Saudi Arabia
基金
美国国家卫生研究院;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; TIOTROPIUM BROMIDE; ADULT PATIENTS; INHALED CORTICOSTEROIDS; AIRWAY INFLAMMATION; ACLIDINIUM BROMIDE; UMECLIDINIUM; RESPIMAT(R); RECEPTORS; THERAPY;
D O I
10.1007/s40265-016-0599-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Asthma is a complex disease where many patients remain symptomatic despite guideline-directed therapy. This suggests an unmet need for alternative treatment approaches. Understanding the physiological role of muscarinic receptors and the parasympathetic nervous system in the respiratory tract will provide a foundation of alternative therapeutics in asthma. Currently, several long-acting muscarinic antagonists (LAMAs) are on the market for the treatment of respiratory diseases. Many studies have shown the effectiveness of tiotropium, a LAMA, as add-on therapy in uncontrolled asthma. These studies led to FDA approval for tiotropium use in asthma. In this review, we discuss how the neurotransmitter acetylcholine itself contributes to inflammation, bronchoconstriction, and remodeling in asthma. We further describe the current clinical studies evaluating LAMAs in adult and adolescent patients with asthma, providing a comprehensive review of the current known physiological benefits of LAMAs in respiratory disease.
引用
收藏
页码:999 / 1013
页数:15
相关论文
共 50 条
  • [41] Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
    Mineo Katsumata
    Tomoyuki Fujisawa
    Yosuke Kamiya
    Yuko Tanaka
    Chiaki Kamiya
    Yusuke Inoue
    Hironao Hozumi
    Masato Karayama
    Yuzo Suzuki
    Kazuki Furuhashi
    Noriyuki Enomoto
    Yutaro Nakamura
    Naoki Inui
    Masato Maekawa
    Mitsutoshi Setou
    Hiroshi Watanabe
    Koji Ikegami
    Takafumi Suda
    BMC Pulmonary Medicine, 22
  • [42] Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
    Katsumata, Mineo
    Fujisawa, Tomoyuki
    Kamiya, Yosuke
    Tanaka, Yuko
    Kamiya, Chiaki
    Inoue, Yusuke
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Maekawa, Masato
    Setou, Mitsutoshi
    Watanabe, Hiroshi
    Ikegami, Koji
    Suda, Takafumi
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [43] Comparison Of The Pharmacological Profile Of Long-Acting Muscarinic Antagonists On Isolated Human Bronchi
    Naline, E.
    Delyle, S. Grassin
    Salvator, H.
    Devillier, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [44] Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus
    Naline, Emmanuel
    Delyle, Stanislas Grassin
    Salvator, Helene
    Brollo, Marion
    Faisy, Christophe
    Victoni, Tatiana
    Abrial, Charlotte
    Devillier, Philippe
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 46 - 53
  • [45] Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs
    Casarosa, Paola
    Bouyssou, Thierry
    Germeyer, Sabine
    Schnapp, Andreas
    Gantner, Florian
    Pieper, Michael
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02): : 660 - 668
  • [46] Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease
    Jones, Paul W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (03) : 84 - 96
  • [47] Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma
    Santamaria, Francesca
    Ziello, Carla
    Lorello, Paola
    Bouche, Cristina
    Borrelli, Melissa
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [48] Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study
    Jusufovic, Edin
    Zugic, Vladimir
    Kosnik, Mitja
    Drvenica, Mirjana Jovancevic
    Hromis, Sanja
    Nurkic, Jasmina
    Al-Ahmad, Mona
    Kardum, Ljiljana Bulat
    Sejdinovic, Rifat
    Prnjavorac, Besim
    Jusufovic, Azra
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [49] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [50] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
    Evans, David J. W.
    Kew, Kayleigh M.
    Anderson, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):